Fresenius | FRE - Loan Capital

Stock Price
44.75
Daily Change
1.55 3.59%
Monthly
-5.07%
Yearly
27.24%
Q2 Forecast
42.30

Fresenius reported EUR10.8B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akzo Nobel EUR 3.67B 13M Dec/2025
Alcon AG USD 4.59B 0 Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Beiersdorf EUR 117M 15M Dec/2025
DaVita Healthcare Partners USD 10.16B 19.88M Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
E.ON EUR 34.05B 869M Dec/2025
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Getinge SEK 8.92B 640M Dec/2025
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GN Store Nord DKK 8.9B 9M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Philips EUR 6.93B 303M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
RWE EUR 15.51B 129M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025